HK-listed pharmaceutical company China NT Pharma Group Company Limited has entered into an agreement to acquire a 40 per cent stake in Beijing Konruns Pharmaceutical’s unit Kangchen for 360 million yuan ($51 million) in a bid to reshuffle its business.